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Function in Allergic Contact Hypersensitivity
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Beatrice Richter1, Karolin Zachmann1, Sascha Cording3, Anna Claßen1,2, Richard Brans2,4, Alf Hamann3,
Jochen Huehn3,5 and Michael P. Schön1,2
Murine contact hypersensitivity (CHS) is a dendritic cell (DC)-dependent T-cell-mediated inﬂammation with
CD8+ T cells as effectors and CD4+ T cells as regulators (Treg cells) that models human allergic contact dermatitis.
The integrin αE(CD103) is expressed by some T-cell and DC subsets and has been implicated in epithelial
lymphocyte localization, but its role in immune regulation remains enigmatic. We have identiﬁed a function for
CD103 in the development of cutaneous allergic immune responses. CHS responses, but not irritant contact
dermatitis, were signiﬁcantly augmented in CD103-deﬁcient mice in hapten-challenged skin. Phenotype and
function of skin DCs during sensitization were normal, whereas adoptive transfer experiments revealed that the
elevated CHS response in CD103-deﬁcient mice is transferred by primed T cells and is independent of resident
cells in recipient mice. While T-cell counts were elevated in challenged skin of CD103-deﬁcient mice, the FoxP3
expression level of CD4+CD25+ Treg cells was signiﬁcantly reduced, indicating impaired functionality. Indeed,
Treg cells from CD103-deﬁcient mice were not able to suppress CHS reactions during the elicitation phase.
Further, CD103 on FoxP3+ Treg cells was involved in Treg retention to inﬂamed skin. These ﬁndings indicate an
unexpected dichotomous functional role for CD103 on Treg cells by modulating FoxP3 expression.
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INTRODUCTION
Contact hypersensitivity (CHS) in mice resembles human
allergic contact dermatitis and, therefore, is a relevant model
to study mechanisms underlying this common and burdensome
condition (Becker, 2013; Mahler et al., 2014). CHS is a
dendritic cell (DC)-dependent T-cell-mediated immune
response following epidermal sensitization and subsequent
challenge with the relevant hapten (Grabbe and Schwarz,
1998; Nosbaum et al., 2009). During sensitization, the skin is
exposed to a speciﬁc hapten for the ﬁrst time. Cutaneous DC
take up the hapten, become activated through local production
of pro-inﬂammatory mediators and migrate to draining
lymph nodes (dLNs) where they prime hapten-speciﬁc
T cells. Although for a long time, epidermal Langerhans cells
(LCs) were considered to be the only DCs able to initiate CHS,
more recent studies suggested that dermal DCs also contribute
to its pathogenesis (Bennett et al., 2007; Vocanson et al., 2009;
Honda et al., 2013). The inﬂammatory elicitation (or challenge)
phase after subsequent contact with the same hapten features
an antigen-speciﬁc T-cell response along with profound
inﬁltration of cells of the innate immune system. The clinical
correlate is skin inﬂammation with edema, hyperemia, and
epidermal damage, which peaks at 24–48 hours after
re-exposure and progressively declines by different down-
regulating mechanisms (Akiba et al., 2002).
Both CD4+ and CD8+ T cells contribute to inﬂammatory
responses. Hapten-speciﬁc CD8+ cytotoxic T cells producing
IFNγ and IL-17 are the primary effector cells in murine CHS to
haptens such as oxazolone (OXA) or DNFB (Bour et al., 1995;
Kehren et al., 1999; Akiba et al., 2002). CD4+ regulatory T
(Treg) cells control the expansion of hapten-primed effector
CD8+ T cells and modulate the severity of CHS, presumably
through production of IL-10 (Bour et al., 1995; Gorbachev
and Fairchild, 2004; Ring et al., 2006; Ring et al., 2011).
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However, the mechanisms underlying the ﬁne-tuning of the
“amplitudes” of such contact allergic reactions by Treg cells,
the phenotype of Treg cells involved as well as Treg trafﬁcking
to and retention within the skin, are not yet fully understood.
The integrin αE(CD103) is primarily expressed by epithelial
lymphocytes of the intestine, lung, and skin, but also by
subsets of mucosal mast cells, mucosal DCs, and dermal DCs
(Kilshaw, 1999; Schön et al., 2002; Pribila et al., 2004).
Although its function on DCs and mast cells remains elusive,
it is thought that CD103 is not only involved in retention of
lymphocytes to epithelial tissues but also in shaping and
proper intraepithelial morphogenesis (Schön et al., 1999;
Schlickum et al., 2008), as its only known ligand, E-cadherin,
is expressed by epithelial cells such as keratinocytes and
LCs (Cepek et al., 1994; Karecla et al., 1995; Kilshaw, 1999;
Pauls et al., 2001). Thus, the number of CD103-expressing
lymphocytes is often increased in inﬂammatory skin diseases.
Some studies suggested that CD103 expression on Treg cells
but not on effector T cells is mandatory for their retention in
inﬂammatory lesions and that dysregulation of CD103 leads
to imbalanced local immunoregulation in the skin with
augmented inﬂammatory responses (Lehmann et al., 2002;
Siegmund et al., 2005; Sufﬁa et al., 2005). However, the
points at which CD103 is required during this complex
multistep immune response have not been clearly delineated.
We demonstrate that CHS developing in the absence of
CD103 is more severe compared with wild-type (wt) mice.
Moreover, while the number of T cells was increased, CD103
deﬁciency leads to a diminished FoxP3 expression on Treg
cells suggesting a functional role. However, although CD103
is not mandatory for T-cell localization per se, it is crucial for
Treg retention during CHS. Thus, it appears that CD103
deﬁciency augments inﬂammatory responses due to defective
regulatory mechanisms by affecting both Treg function and
retention.
RESULTS
Increased CHS reaction in CD103-deﬁcient mice
CHS was induced using two different obligate haptens,
namely OXA and 1-chloro-2,4-dinitrobenzene, in a large
number of CD103-deﬁcient mice and their wt counterparts
(detailed in the legend to Figure 1a). The mice were sensitized
on their shaved lower backs and challenged 5 days later on
their right ears (the left ears served as internal vehicle
controls). Although the overall dynamics of ear thickness as
a surrogate parameter of cutaneous inﬂammation were similar
in both genotypes, CD103-deﬁcient mice developed a
signiﬁcantly stronger ear swelling response throughout the
entire observation period. The difference in ear thickness
between the strains became signiﬁcant as early as 8–24 hours
after the challenge, with a peak at 32–48 hours (Po0.001,
Po0.01 or Po0.05, Figure 1a). Control mice, which were
only challenged with either of the two haptens, did not mount
an increased ear swelling, neither in wt, nor in CD103− /−
mice (data not shown).
To assess whether the observed differences were speciﬁc
for allergic immune reactions, we induced irritant contact
dermatitis using Croton oil, which elicits acute inﬂammation
without sensitization and, therefore, addresses innate immune
responses in a T-cell-independent manner (Nosbaum et al.,
2009). The typical biphasic Croton oil-induced ear swelling
response as a parameter for acute irritant inﬂammation was
observed as early as 1 hour after exposure, with peak values
after 6–8 hours (Figure 1b). Of note, there were no signiﬁcant
differences between CD103− /− and wt animals. In addition,
cutaneous inﬁltration of mononuclear and polymorpho-
nuclear leukocytes was similar in both genotypes (data not
shown). Thus, deﬁciency of CD103 did not directly affect
acute inﬂammatory processes.
When OXA-sensitized mice were evaluated histopatholo-
gically to assess the tissue distribution of various cell types
involved in inﬂammatory processes, OXA-challenged skin
showed a profound mixed inﬂammatory inﬁltrate including
mononuclear, polymorphonuclear, and mast cells within the
dermis, all of which were conspicuously more prominent
in CD103-deﬁcient mice (Figure 1c, four upper panels).
Immunohistochemistry revealed massive dermal recruitment
of CD11b+ myeloid lineage cells (monocytes/macrophages)
and Gr1+ granulocytes, respectively, into inﬂamed skin
(Figure 1c, four lower panels). Used as a second independent
and quantitative method, ﬂow cytometric analyses revealed
markedly higher numbers of immigrating CD11b+monocytes/
macrophages, CD11b+/Gr1+ neutrophils, and F4/80+ macro-
phages upon OXA challenge in CD103− /− mice. Paralleling
the macroscopic observations, these differences were most
pronounced at 36 hours after OXA challenge (Figure 1d).
Furthermore, a higher percentage of CD11b+ and CD11b+/
Gr1+, but not F4/80+ cells cells within the inﬁltrate of
CD103− /− mice became apparent. As these innate effector
cells do not express CD103, they might not be the primary
cell types mediating the observed differences. Therefore, we
hypothesized that the stronger CHS-induced inﬂammation in
CD103-deﬁcient mice was due to altered function of cells
expressing CD103, either DCs or T cells.
Normal DC function in CD103− /− mice during T-cell priming in
the sensitization phase
Given that priming of hapten-speciﬁc T cells by DCs,
particularly epidermal LCs, in dLNs during sensitization is
mandatory in CHS (Grabbe et al., 1995; Bennett et al., 2007)
and because the density of LCs inﬂuences CHS responses
(Bennett et al., 2007; Vocanson et al., 2009), we examined
DC migration, homing, maturation, and function in wt and
CD103-deﬁcient mice. On the basis of morphometric
analyses of epidermal sheet preparations, we found that
in situ counts and morphology of LCs showed no signiﬁcant
differences between CD103− /− and wt mice (Figure 2a),
suggesting that CD103 was not required for the orthotopic
localization and morphogenesis of LCs within the epidermis
under steady-state conditions.
To elucidate the migration of skin DCs to the dLN, we
followed DC migration after cutaneous painting with the
ﬂuorescent hapten, FITC, and analyzed FITC-loaded cells
recovered from dLN by ﬂow cytometry. All FITC-containing
cells were MHCII/CD11c-positive, thus being DC migrated
from the skin. Indeed, migration of DCs was restricted to dLN,
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as non-dLN and spleen did not harbor any FITC-positive cells,
irrespective of the mouse strain used (data not shown).
Approximately 2.5–3.0×105 antigen-loaded DCs migrated to
each dLN in both CD103− /− and wt mice with similar
dynamics for an observation period of up to 72 hours
(Figure 2b). To assess DC phenotypes, classical DC activation
markers including the adhesion molecule, CD62L (L-selectin),
the chemokine receptor, CCR7, regulating homing and
trafﬁcking of DC from the skin to secondary lymphoid tissues,
and the co-stimulatory molecules CD40, CD83, and CD86,
respectively, were assessed by ﬂow cytometry. Expression of
these markers was similar within the FITC-positive popula-
tions of both strains (Figure 2c). Further analysis of FITC-
loaded skin-derived DC in dLN of wt mice showed that the
vast majority did not express CD103 (12.16% (SEM= 2.07%);
data not shown) and are, therefore, presumably LCs, as these
cells do not express CD103.
In functional activation experiments, bone marrow–derived
DCs (BMDCs) from CD103− /− mice stimulated hapten-speciﬁc
CD4+ or CD8+ T-cell proliferation with equal efﬁciency
compared with BMDCs from wt mice (Supplementary Figure
S1 online). This indicated that CD103 expression on DCs was
not required for the stimulation of antigen-reactive T cells in
CHS. BMDC preparations from both CD103− /− and wt mice
contained485% DCs as assessed by the expression of CD11c
(data not shown), and their maturation phenotype was identical
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Figure 1. Increased allergic contact hypersensitivity (CHS), but normal irritant contact dermatitis in CD103− /−mice. (a) Normalized ear swelling of oxazolone
(OXA)- or DNCB-treated wild-type (wt) and CD103− /− mice were measured as differences in ear thickness in at least four independent experiments (n= 10–42;
mean± SEM), respectively. (b) Ear swelling after Croton oil-induced irritant contact dermatitis are displayed (n=11–12; mean ± SEM). (c) At 36 hours after
challenge, representative tissue sections (out of three) were stained with hematoxylin and eosin (HE), Giemsa-solution, or antibodies against CD11b or Gr1.
Examples of mast cells in the Giemsa-stained sections are indicated by arrows. Scale bars=50 μm. (d) Ear cells of wt and CD103− /− mice were analyzed for
CD11b+, CD11b+/Gr1+, and F4/80+ expression by ﬂow cytometry. (n=3–7; mean ± SEM). *Po0.05; **Po0.01 (unpaired Student’s t test). DNCB, 1-chloro-2,4-
dinitrobenzene.
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with respect to MHCII, CD86 and CD40 expression (Supple-
mentary Figure S1 online).
Altered DC functions during the elicitation phase cannot be
formally excluded. A recent study demonstrated that dermal
dendritic cells form clusters with effector T cells during the
elicitation phase leading to optimal antigen-speciﬁc activa-
tion and proliferation of T cells (Natsuaki et al., 2014).
CD103 deﬁciency increases cutaneous T-cell inﬁltration in CHS
Both CD8+ and CD4+ T cells act as either effector or
regulatory cells in CHS through the production of IFNγ and/or
IL-4/IL-10 (Vocanson et al., 2009; Honda et al., 2013). Given
that early CD8+ T-cell inﬁltration induces skin inﬂammation
in CHS (Bour et al., 1995; Kehren et al., 1999; Akiba et al.,
2002), we assessed T-cell inﬁltration into mouse ears 24 hours
after OXA challenge, i.e., prior to the massive macrophage
and granulocyte recruitment into the skin. While the total cell
numbers of CD103− /− ears did not differ signiﬁcantly from wt
ears, the number of T cells (TCRαβ+) was signiﬁcantly
increased in ears of CD103− /− mice by 62.4% (Po0.01;
Figure 3a). Similar differences were seen when CD8+ and
CD4+ T-cell populations and even CD4+CD25+Treg cells
were analyzed separately (Figure 3a). The relative composi-
tion of the T-cell inﬁltrate was not different between the two
strains, indicating that T-cell populations increased equally
(data not shown).
Likewise, analyses of skin dLN during the elicitation phase
revealed a signiﬁcantly more pronounced inﬂammation in
CD103− /− mice, as evinced by higher total leukocyte counts
as well as elevated numbers of TCRαβ+, CD8+, CD4+,
and CD4+CD25+ T cells (Po0.01 or Po0.001 in all
cases; Figure 3b). Therefore, the “clinical” increase of CHS
responses in CD103-deﬁcient mice was associated with
increased T lymphocyte inﬁltration/recruitment to sites of
cutaneous inﬂammation as well as into the dLN.
CD103 deﬁciency–dependent increase of CHS is mediated by
T cells in adoptive transfer experiments
To directly examine the role of primed T cells for the CHS
response, naïve wt or CD103− /− mice were injected
intravenously with dLN cells from OXA-sensitized wt
or CD103− /− donor mice. Compositions of cell suspension
were comparable between strains with 25.86± 0.93% and
29.48± 0.62% total TCRαβ+ cells including 62.6± 0.65%/
63.86± 1.12% CD4+ T cells and 31.4± 0.68%/30.63±1.2%
CD8+ T cells in wt and CD103− /− mice, respectively (data
not shown). When these adoptively transferred mice were
challenged, primed dLN cells from CD103− /−mice induced a
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signiﬁcantly more pronounced ear swelling response com-
pared with transfer of dLN cells from wt mice, irrespective of
the recipient genotype (increase by 28.3–67.8% after 32
hours; Po0.01 or Po0.001 in all cases; Figure 3c). Thus,
T cells were fully primed, homed to the skin, and elicited a
CHS response, which was signiﬁcantly enhanced when
CD103 was lacking, supporting the hypothesis that increased
CHS responses in CD103− /− mice were mediated by altered
T-cell functions.
Interestingly, transfer of dLN cells from CD103− /− donor
mice into wt recipient mice induced a signiﬁcantly higher ear
swelling response than transfer of these cells into CD103− /−
recipient mice (increase by 126% after 32 hours; Po0.05;
Figure 3c). We cannot explain this discrepancy by now, but it
is conceivable that other cells are involved in the regulation of
the skin response (Natsuaki et al., 2014).
To further elucidate the role of hapten-speciﬁc lympho-
cytes and to exclude intrinsic T (and B)-cell biases, we
adoptively transferred dLN cells from previously sensi-
tized animals into immunodeﬁcient Rag1− /− mice devoid
of functional T and B cells. Again, adoptive transfer of
CD103− /− dLN cells correlated with a signiﬁcantly stronger
ear swelling response compared with the transfer of wt
cells (increase by 35.5% after 32 hours; Po0.001; Figure 3d).
These results indicated that elevated CHS responses in
CD103− /− mice were primarily, if not exclusively, transferred
by primed T cells and (largely) independent of resident cells in
recipient mice.
When dLNs from OXA-sensitized mice were adoptively
transferred into Rag1-deﬁcient mice and the recipients were
challenged with DNFB, the minuscule ear swelling responses
in mice reconstituted with either wt or CD103-deﬁcient dLN
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cells were identical to those of mice without transfer (n= 3;
mean ± SEM), thus indicating antigen speciﬁcity.
Ex vivo hapten-speciﬁc T-cell responses are augmented in
CD103− /− mice
To further dissect the impact of CD103 on CD4+ and CD8+
T-cell function, we assessed the ability to recall a hapten-
speciﬁc T-cell response, i.e., the proliferative response of
in vivo primed T cells upon re-stimulation with haptenized
BMDC in vitro. Interestingly, a higher portion of CD8+ T cells,
but not CD4+ T cells, proliferated in CD103− /− mice com-
pared with wt mice (increase by 25%; Po0.01;
Figure 4a) indicating a role of CD103 in T-cell proliferation.
It is conceivable that proliferation of CD8+ T cells is either
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median; the dotted line indicates a ratio of 1). **Po0.01 (Wilcoxon signed-rank test compared with a hypothetical value of 1). BMDC, bone marrow–derived
dendritic cell; CFSE, carboxyﬂuorescein diacetate succinimidyl ester; DNBS, 2,4-dinitrobenzenesulfonic acid hydrate.
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affected directly or the higher turnover is due to impaired
regulatory mechanisms, a hypothesis that was tested in the
following experiments.
Augmented CHS responses in CD103-deﬁcient mice are
associated with alterations of FoxP3+ Treg cells
Treg cells are a critical CD4+ T-cell population controlling
immune homeostasis and regulating inﬂammation (Sakaguchi
et al., 2008; Rudensky, 2011). Many studies have described
their capability to suppress CHS responses by limiting the
expansion of hapten-primed effector CD8+ T cells (Dubois
et al., 2003; Gorbachev and Fairchild, 2004; Ring et al., 2006;
Ring et al., 2011; Honda et al., 2013). In consequence,
enhanced and prolonged inﬂammation might result from
diminution of Treg activity, which can, in principle, be caused
by defective function, trafﬁc, and/or retention.
Besides high expression of the IL-2 receptor α-chain
(CD25), the best Treg marker is the transcriptional regulator
forkhead-box P3 (FoxP3), which is restricted to the Treg
lineage and is thought to be a master regulator for Treg
maturation and function (Fontenot et al., 2005). When we
assessed FoxP3 expression within the cutaneous CD4+CD25+
T-cell population 24 hours after challenge, its expression in
this population was higher by 37.7% in wt compared with
CD103− /− mice (Po0.05; Figure 4b). Because the intensity of
FoxP3 expression is linked to the functionality of Treg cells
(Rudensky, 2011), these data indicate a higher suppressive
capacity of wt Treg cells.
Treg cells can, in principle, suppress immune reactions
either at peripheral effector sites or during the expansion and
differentiation of T cells in the dLN (Dubois et al., 2003;
Vocanson et al., 2009). However, the FoxP3 expression levels
within the dLN were not signiﬁcantly different in our two
genotypes (Figure 4b). Thus, we conclude, that CD103 was
involved in in situ Treg function within the skin, but not at the
level of dLN.
Consistent with this notion, CD103 is thought to facilitate
adhesion, retention, and morphogenesis of lymphocytes
within epithelial tissues (Kilshaw, 1999; Schön et al., 1999;
Schlickum et al., 2008), including inﬂamed skin, but not
peripheral lymph nodes (Lehmann et al., 2002; Siegmund
et al., 2005; Sufﬁa et al., 2005). Indeed, in wt mice, we
determined that CD103 was poorly expressed on Treg cells
within lymphoid tissues, but highly expressed within the skin
(20% in dLN vs. 80% in the skin of total Treg cells; data not
shown), which is consistent with previous reports (Lehmann
et al., 2002; Anz et al., 2011).
Treg cells from CD103-deﬁcient mice fail to suppress CHS
effector reactions
To further determine the role of Treg cells for the suppression
of CHS effector reactions, we adoptively transferred naïve
Treg cells into reconstituted Rag1− /− recipient mice. As
expected, transfer of Treg cells from wt mice strongly
suppressed the ear swelling in Rag1− /− recipient mice after
challenge with OXA (Figure 4c). In contrast, ear swelling of
Rag1− /− recipient mice reconstituted with Treg cells from
CD103− /− mice was comparable with that of Rag1− /− mice
without any Treg cells (Figure 4c). These data demonstrate
that CD4+CD25+ Treg cells lacking CD103 are unable to
regulate cutaneous inﬂammatory reactions.
CD103 supports the retention of Treg cells in CHS
Besides the involvement of CD103 in regulatory functions of
Treg cells, its expression has been implicated in T-cell
recruitment and/or retention during inﬂammation, e.g., in
Leishmania-mediated skin inﬂammation (Sufﬁa et al., 2005).
We further investigated the role of CD103 expression on Treg
cells for their localization to inﬂamed skin in a slightly
modiﬁed CHS model using repetitive sensitization with the
strong hapten DNFB. For this purpose, mixed bone marrow
(BM) chimeric mice were generated by reconstituting lethally
irradiated mice with BM from wt and CD103− /− donor mice
at a 1:1 ratio. The proportion of wt (Thy1.1+) and CD103− /−
(Thy1.2+) Treg cells detected within the inﬂamed ears upon
hapten challenge was then monitored over time by ﬂow
cytometry. Of note, 96 hours after the challenge, wt Treg cells
were detected at signiﬁcantly higher numbers compared with
their CD103− /− counterparts (increase by 25%; Po0.01;
Figure 4c).
Taken together, we conclude that the higher number of
inﬁltrating TCRαβ T cells in the skin of CD103− /− mice is a
consequence of insufﬁcient termination or quenching of the
immune response due to both altered Treg function and
retention.
DISCUSSION
The function of the αE(CD103) integrin for immune responses
is still enigmatic in many aspects. We have now provided
experimental evidence that this receptor is important for the
regulation of allergic CHS in mice. By using two different
haptens, namely OXA and 1-chloro-2,4-dinitrobenzene, we
could show that this dysregulation is independent of the
model used, T helper type 1 or T helper type 2, respectively.
Although CD103 was expressed by subsets of both T
lymphocytes and DCs, the latter potentially possessing
regulatory functions (Annacker et al., 2005; Coombes et al.,
2007; Honda et al., 2013), we could not detect altered DC
functions during the pathogenesis of CHS. The skin harbors
different subsets of DCs, which seem not only to have
different but also redundant roles during CHS (Edelson et al.,
2010; Noordegraaf et al., 2010; Romani et al., 2010). Instead,
the lack of CD103 on Treg cells was associated with the
enhanced cutaneous inﬂammation during CHS in CD103-
deﬁcient mice compared with their wt counterparts. Of note,
the function of CD103 appeared to be dichotomous: On the
one hand, CD103 was associated with higher expression of
FoxP3 in Treg cells, and thus it is likely that Treg cell function
is altered. On the other hand, it contributed to the retention of
Treg cells at sites of inﬂammation. CD103 is relevant for
tissue-speciﬁc localization not only of CD8+ epidermal T cells
(Pauls et al., 2001) and CD8+ resident memory T cells
(Gebhardt and Mackay, 2012), but also of CD4+CD25+ Treg
cells (Sufﬁa et al., 2005). Our ﬁndings extend previous studies
showing that CD103 expression on CD4+CD25+ Treg cells,
but not on CD4+CD25− effector T cells, was necessary for
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their retention at the site of Leishmania major infection. As a
consequence, CD103+ Treg cells interfered with the
clearance of this infection (Sufﬁa et al., 2005). How and to
what extent CD103-expressing CD4+ and/or CD8+ effector/
resident-memory T cells are involved in the pathogenesis of
CHS is not clear (Gebhardt and Mackay, 2012).
By contrast, in CD103-expressing tumor-inﬁltrating FoxP3+
Treg cells, CD103 was not involved in homing or retention of
FoxP3+ cells within the tumor tissue, but rather in mediating
their suppressive function (Anz et al., 2011). Indeed, CD103
expression on tumor-inﬁltrating FoxP3+ Treg cells increased
the potency of these cells (Lehmann et al., 2002; Anz et al.,
2011), suggesting that Treg cells from CD103− /− mice might
be ineffective regarding their suppressive capacity. This
supports previous studies suggesting that CD103 is a marker
for a subset of Treg cells with high suppressive capacity
(Lehmann et al., 2002; Banz et al., 2003).
As of now, the exact mechanisms of how Treg cell
functions are controlled are not fully understood. CD103
expression on Treg cells may have different implications
when studying different inﬂammatory processes, such as
colitis, tumor growth, or skin infection. Thus, the concept of a
tissue-speciﬁc regulation is a reasonable hypothesis, although
modifying factors have not been identiﬁed yet. In addition, the
mechanistic link between CD103 and FoxP3 expression
remains unknown. Although the molecular interplay between
CD103 expression versus CD103 ablation and FoxP3 regula-
tion is not known, it has become clear that the level of FoxP3
expression is directly linked to the suppressive capacity of
Treg cells (Rudensky, 2011), and instability of FoxP3
expression seems to be linked to the ﬂexible adaptation of
regulatory functions (Feuerer et al., 2009). Thus, an impaired
suppressive capacity of Treg cells or even a conversion into
potential effector T cells due to phenotypic alterations and
T-cell plasticity might be responsible, at least in part, for the
enhanced CHS responses in CD103− /− mice. The regulation
of FoxP3 expression in CD103+ and CD103− Treg cells and
their suppressvie capacity is, therefore, an interesting open
question.
Moreover, expression of both CD103− and FoxP3 is
induced by transforming growth factor (TGF)-β.14 Indeed,
TGFβ induces CD103 expression on T cells and even the
generation of CD103-expressing FoxP3+ Treg cells from naïve
T cells in vitro (Pauls et al., 2001; Rao et al., 2005). Thus,
increased levels of TGFβ, which are present in the local
microenvironment during inﬂammatory processes, might
contribute to the Treg-mediated control of inﬂammation by
a feed-forward-loop, as much as CD103 expression mediates
increased Treg retention which leads to the upregulation of
FoxP3 due to the presence of TGFβ. This seems to be likely for
CD103+ tumor-inﬁltrating Treg cells (Anz et al., 2011) or Treg
cells during gastrointestinal parasite infections (Reynolds and
Maizels, 2012). It is conceivable that this is true for Treg cells
during skin inﬂammation as well, where CD103-mediated
retention exposes Tregs to TGFβ within the epithelial
microenvironment for a longer period of time, thus enhancing
their FoxP3 expression. To further address the question of
T-cell plasticity, it is likely that previously non-regulatory
T cells are converted to CD103+ Treg cells in the presence of
TGFβ.
It is reasonable to assume that unraveling the molecular
crosstalk between CD103 and FoxP3 will provide a handle
on targeting regulatory mechanisms in inﬂammation. It is also
conceivable that CD103 is involved in transcriptional
regulation of other surface molecules, chemokines, or
cytokines, which are crucial for trafﬁc and function of Treg
cells, thus acting indirectly. In any case, our study of CHS
now provides experimental evidence that CD103 is involved
in the “ﬁne-tuning” of T-cell–mediated skin inﬂammation
through inﬂuencing retention and FoxP3 expression of
Treg cells.
MATERIALS AND METHODS
Mice
C57BL/6J wt, Rag1− /− (The Jackson Laboratory, Bar Harbor, ME)
and αE(CD103)-deﬁcient (CD103− /−) mice (Schön et al., 1999)
backcrossed on C57BL/6J genetic background were bred at the
animal care facility of the University Medical Center Göttingen.
For chimeric mice experiments, Balb/c (Bundesinstitut für
Risikobewertung, BfR, Berlin, Germany), congenic Thy1.1xBalb/c
and CD103− /−mice on a Balb/c background were bred at the animal
facility of the German Rheumatism Research Center (DRFZ,
Berlin, Germany). Mice were housed under speciﬁc pathogen-free
conditions with food and water ad libitum. Age-matched mice
(8–12 weeks) were used in all experiments. All animal experiments
were performed in accordance with the institutional, state, and
federal guidelines and were approved by local institutional animal
care advisory committees and the respective permit authorities.
Allergic CHS
Mice shaved on their lower back were sensitized once topically with
100 μl of 3% OXA (w/v) (4-ethoxymethylene-2-phenyl-2-oxazolin-5-
one; Sigma Aldrich, Munich, Germany) or 1% 1-chloro-2,4-
dinitrobenzene (Sigma Aldrich). On d5, mice were challenged with
20 μl of 1% OXA or 1% 1-chloro-2,4-dinitrobenzene on the right ear
and 20 μl of vehicle (ethanol) on the left ear. Ear thicknesses were
measured using a digital caliper (Kroeplin, Schlüchtern, Germany),
and the increase in ear swelling was determined as the normalized
difference of ear thicknesses between the OXA-treated versus the
vehicle-treated side of the same mouse.
For experiments using chimeric mice, mice were sensitized with
20 μl of 0.5% DNFB (Sigma Aldrich) in acetone/oil (4:1; v/v) on d0
and d2. On d4, mice were challenged with 10 μl/ear of 0.2% DNFB.
Single-cell suspensions of ears and spleen were prepared and
assessed by ﬂow cytometric analyses.
Irritant CHS
Acute irritant inﬂammatory reactions were induced by paining 20 μl
of 2.5% Croton oil (Sigma Aldrich) in acetone (v/v) or the vehicle
(acetone) to the right ear. Increase in ear swelling was measured as
described above.
Migration, homing, and maturation assay in vivo
For migration assays, mice were painted once with 200 μl of 1% FITC
Isomer I (Merck Millipore, Schwalbach, Germany) in acetone/DBP
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(1:1; v/v). Cells from the inguinal dLN were isolated and processed
further for ﬂow cytometric analyses.
Adoptive transfer experiments
On d5 after sensitization, dLNs were prepared and single cell
suspensions of 2× 107 sensitized dLN cells in 150 μl phosphate-
buffered saline were transferred via retro-orbital injection into
anesthetized recipient mice. For adoptive transfer of Treg cells,
CD4+CD25+ cells were enriched from naïve mice using the
“Regulaotry T cell Isolation Kit” (Miltenyi, Bergisch Gladbach,
Germany) and 5× 105 Treg cells were injected together with dLN
per recipient mouse. After 24 and 32 hours, the mouse ears were
challenged with 1% OXA to induce CHS.
Generation of chimeric mice
Recipient Balb/c mice received Enroﬂoxacin (Bayer, Leverkusen,
Germany) in sterile drinking water ad libitum for 1 week.
Subsequently, mice were lethally irradiated (10.5 Gy) using a
gamma irradiation device (Rad Source Technologies, Suwanee, GA).
One day later, BM cells from donor mice were depleted from mature
CD90+lymphocytes (e.g., Thy1.1+ in wt (Balb/cxThy1.1) and
Thy1.2+ in CD103− /− donors) by magnetic depletion using an
AutoMACSPro separator (Miltenyi) according to the manufacturer’s
instructions. CD90-depleted BM from wt and CD103− /− donors was
then combined at a 1:1 ratio and 5× 106 cells were injected
intravenous into irradiated recipient mice. Mice continuously
received the antibiotic regimen with Enroﬂoxacin for another
4 weeks. Five weeks later, chimerism was certiﬁed in peripheral
blood and successfully engrafted mice were subjected to experi-
mental procedures after 5–6 weeks of reconstitution.
Generation of BMDCs
BMDCs were generated as described previously (Lutz et al., 1999;
Braun et al., 2010). Brieﬂy, BM cells from femur and tibiae were
cultured (2× 106) in the presence of 10% (v/v) murine GM-CSF-
containing supernatant (Zal et al., 1994) for 8 days. Subsequently,
non-adherent cells were loaded with 0.5 mM DNBS (2,4-dinitroben-
zenesulfonic acid hydrate; Sigma Aldrich) for 24 hours and assessed
for expression of the indicated cell surface markers and used in
hapten-speciﬁc T-cell proliferation assays.
Ex vivo hapten-speciﬁc T-cell proliferation
For ex vivo proliferation assays, mice were sensitized with 100 μl
0.3% DNFB in acetone/oil (4:1; v/v) and on day 5 dLN cells were
isolated. Carboxyﬂuorescein diacetate succinimidyl ester-stained
(1× 105; Sigma Aldrich) cells were co-cultured with DNBS-
stimulated BMDCs at the indicated for 72 hours. Cell division was
analyzed by measuring carboxyﬂuorescein diacetate succinimidyl
ester on CD4+ and CD8+ T cells using ﬂow cytometry.
Histology and immunohistochemistry
For morphological analyses, mouse ears were either deep frozen in
Tissue-Tek O.C.T. Compound (Sakura Finetek, Leiden, Netherlands)
or ﬁxed in 4% paraformaldehyde solution (v/v) and subsequently
embedded in parafﬁn. For immunohistochemical analyses of
epidermal sheets, ear halves were incubated in 50mM EDTA/
phosphate-buffered saline (v/v) and the epidermis was peeled off
the connective tissue.
Hematoxylin and eosin-staining was performed using parafﬁn-
embedded sections of 3 μm. For Giemsa-staining, samples were
incubated with Giemsa-solution (Sigma Aldrich) and differentiated
with 0.1% acetic acid (v/v). During immunohistochemistry, 5 μm
sections of frozen samples were ﬁxed with methanol, followed
by inactivation of endogenous peroxidase with 0.3% H2O2,
blocking of endogenous biotin with Biotin-Blocking System (DAKO,
Hamburg, Germany) and unspeciﬁc binding with 5% rabbit
serum. The samples were incubated with the respective primary
antibody (CD11b, M1/70, Immunotools, Friesoythe, Germany; Gr1,
RB6–8C5, BD, Heidelberg, Germany) followed by incubation
with the relevant horseradish peroxidase-labeled secondary anti-
body (Vector, Burlingame, CA). After incubation with streptavidin-
peroxidase (Vector) and AEC+-Solution (DAKO), samples were ﬁnally
counterstained with hematoxylin (DAKO). Microscopic analyses
were performed using an Axioskop2 (Zeiss, Göttingen, Germany)
microscope and the Axiovision software Rel 4.7 (Zeiss).
Flow cytometry (ﬂuorescence-activated cell sorting analysis)
To prepare single cell solution, ears were digested in Liberase solution
(Roche Diagnostics, Mannheim, Germany), homogenized and
ﬁltrated. Lymph nodes were collected, homogenized, and ﬁltrated
on ice. After blocking Fc receptors with anti-mouse CD16/32 mAb
(2.4G2; BD), cells were subsequently stained with indicated mAb: Gr1
(RB6–8C5; Immunotools), CD11b (M1/70; BD), F4/80 (CI:A3-1;
Serotec, Puchheim, Germany), TCRαβ (H57–597; BioLegend, San
Diego, CA or Immunotools), CD4 (RM4–5; BD), CD4 (H129.19;
BioLegend), CD8 (53-6.7; BioLegend or Miltenyi), CD8 (YTS169.4;
Immunotools), CD25 (PC61; BioLegend), CD103 (2E7; BioLegend),
CD11c (N418; BioLegend), MHC class II (M5/114.15.2; BioLegend),
CD40 (2/23; BD), CD86 (GL1; BD), CD62L (MEL-14; Immunotools),
CCR7 (4B12; BioLegend), CD83 (Michel-19; BioLegend), CD90.1
(Thy1.1; HIS51; BD), CD90.2 (Thy1.2; 53-2.1; BD). Intracellular
staining with anti-FoxP3 (MF-14; BioLegend) was performed using the
FoxP3 Buffer Kit (BD) or anti-FoxP3 (FJK-16s; eBioscience, San Diego,
CA) with Mouse Regulatory T Cell Stainig Kit (eBioscience). Viability
was determined using 7-aminoactinomycin D solution (BD) or
Zombie-NIR (BioLegend). The stained cells were detected in the BD
FACSCantoII (BD) and data were analyzed by the FACSDiva software
(BD). Data from chimeric mouse experiments were assessed with LSRII
operated with FACSDiva software (BD) and analyzed by FlowJo-
software (TreeStar, Ashland, OR).
Statistics
Statistical analyses were performed using the unpaired, two-tailed
Student’s t-test to compare groups of independent samples. For
statistical analyses of experiments using chimeric mice, the “Wilcoxon
signed-rank” test was performed in comparison to a hypothetical value
of 1. P-valueso0.05 were considered statistically signiﬁcant.
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